{"id":20170,"date":"2014-04-24T08:06:56","date_gmt":"2014-04-24T12:06:56","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=20170"},"modified":"2014-04-24T08:06:56","modified_gmt":"2014-04-24T12:06:56","slug":"bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170","title":{"rendered":"Bristol-Myers Squibb Co (NYSE:BMY): Strengthen Manufacturing Capability"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 04\/24\/2014 (wallstreetpr) &#8211;\u00a0<b>Bristol-Myers Squibb Co (NYSE:BMY) <\/b>and Samsung BioLogics have extended their manufacturing agreement to develop and produce biologic medicines for Bristol-Myers. Samsung will carry out the manufacturing operation at its Incheon site which is likely to complete by 2015.<\/p>\n<p style=\"text-align: justify;\"><b>Strategic relationship<\/b><\/p>\n<p style=\"text-align: justify;\">Since July 2013, Bristol-Myers Squibb Co (NYSE:BMY)-Myers partnered with Samsung BioLogics to produce commercial antibody drug substance for cancer. Now, both the companies have extended their relationship to strengthen the production capacity and expand its services worldwide. As a result, Bristol-Myers will help to improve its pipeline portfolio for specialty care unit. Consequently, integrated manufacturing facilities will enhance Samsung\u2019s potential in biopharmaceutical segment.<\/p>\n<p style=\"text-align: justify;\"><b>Advantage for Bristol-Myers<\/b><\/p>\n<p style=\"text-align: justify;\">Biologic medicines are primarily used to treat a variety of serious diseases, and Bristol-Myers is one of leading drug markers in biologics space and its specialty care unit has a broad range of biological products including Monoclonal antibodies (MoAs).<\/p>\n<p style=\"text-align: justify;\">The treatment market will continue grow with increasing demand to meet the patients\u2019 unmet needs. The market is highly competitive as a large number of drug makers including small and larger players enter into the market to develop and produce biologic medicines.<\/p>\n<p style=\"text-align: justify;\">IMS also expects that biologics will represent 19-20% of total treatment market value by 2017 due to high growth potential. MoAs and human insulin continue to drive the biologic market and the advent of generic version of the biologic (biosimilars) will further boost the market value in coming years.<\/p>\n<p style=\"text-align: justify;\">In biologics space, Bristol-Myers\u2019 products include Erbitux, Yervoy, Nulojix and Orencia that are well known in the market for their efficiency and safety in the treatment of different chronic diseases. These products have showed positive growth year over year and continue to provide sales growth for the Company.<\/p>\n<p style=\"text-align: justify;\">Bristol-Myers Squibb Co (NYSE:BMY)-Myers also plans to improve its pipeline portfolio and additional production facility will further enhance R&amp;D ability to develop biologics medicines.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 04\/24\/2014 (wallstreetpr) &#8211;\u00a0Bristol-Myers Squibb Co (NYSE:BMY) and Samsung BioLogics have extended their manufacturing agreement to develop and produce biologic medicines for Bristol-Myers. Samsung [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":19777,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[3685,997],"stock_ticker":[],"class_list":["post-20170","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-bristol-myers-squibb-co-nysebmy","tag-nysebmy","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bristol-Myers Squibb Co (NYSE:BMY): Strengthen Manufacturing Capability  - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bristol-Myers Squibb Co (NYSE:BMY): Strengthen Manufacturing Capability  - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 04\/24\/2014 (wallstreetpr) &#8211;\u00a0Bristol-Myers Squibb Co (NYSE:BMY) and Samsung BioLogics have extended their manufacturing agreement to develop and produce biologic medicines for Bristol-Myers. Samsung [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-04-24T12:06:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"275\" \/>\n\t<meta property=\"og:image:height\" content=\"183\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Bristol-Myers Squibb Co (NYSE:BMY): Strengthen Manufacturing Capability\",\"datePublished\":\"2014-04-24T12:06:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170\"},\"wordCount\":325,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg\",\"keywords\":[\"Bristol-Myers Squibb Co (NYSE:BMY)\",\"NYSE:BMY\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170\",\"name\":\"Bristol-Myers Squibb Co (NYSE:BMY): Strengthen Manufacturing Capability - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg\",\"datePublished\":\"2014-04-24T12:06:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg\",\"width\":275,\"height\":183},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bristol-Myers Squibb Co (NYSE:BMY): Strengthen Manufacturing Capability\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bristol-Myers Squibb Co (NYSE:BMY): Strengthen Manufacturing Capability  - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170","og_locale":"en_US","og_type":"article","og_title":"Bristol-Myers Squibb Co (NYSE:BMY): Strengthen Manufacturing Capability  - Wall Street PR","og_description":"Boston, MA 04\/24\/2014 (wallstreetpr) &#8211;\u00a0Bristol-Myers Squibb Co (NYSE:BMY) and Samsung BioLogics have extended their manufacturing agreement to develop and produce biologic medicines for Bristol-Myers. Samsung [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-04-24T12:06:56+00:00","og_image":[{"width":275,"height":183,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Bristol-Myers Squibb Co (NYSE:BMY): Strengthen Manufacturing Capability","datePublished":"2014-04-24T12:06:56+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170"},"wordCount":325,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg","keywords":["Bristol-Myers Squibb Co (NYSE:BMY)","NYSE:BMY"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170","url":"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170","name":"Bristol-Myers Squibb Co (NYSE:BMY): Strengthen Manufacturing Capability - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg","datePublished":"2014-04-24T12:06:56+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/04\/Bristol-Myers-Squibb-Company-1.jpg","width":275,"height":183},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/bristol-myers-squibb-co-nysebmy-strengthen-manufacturing-capability-20170#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Bristol-Myers Squibb Co (NYSE:BMY): Strengthen Manufacturing Capability"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/20170","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=20170"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/20170\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/19777"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=20170"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=20170"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=20170"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=20170"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}